Financial Consulate Has Decreased Aerie Pharmaceuticals In (AERI) Position as Stock Value Declined; Ballentine Partners Continues to Hold Stake in Facebook (FB)

April 23, 2018 - By Darrin Black

Facebook, Inc. (NASDAQ:FB) Logo

Financial Consulate Inc decreased its stake in Aerie Pharmaceuticals In (AERI) by 43.24% based on its latest 2017Q4 regulatory filing with the SEC. Financial Consulate Inc sold 8,000 shares as the company’s stock declined 12.77% with the market. The institutional investor held 10,500 shares of the health care company at the end of 2017Q4, valued at $627,000, down from 18,500 at the end of the previous reported quarter. Financial Consulate Inc who had been investing in Aerie Pharmaceuticals In for a number of months, seems to be less bullish one the $2.15 billion market cap company. The stock increased 1.68% or $0.9 during the last trading session, reaching $54.55. About 89,594 shares traded. Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) has risen 16.25% since April 23, 2017 and is uptrending. It has outperformed by 4.70% the S&P500.

Ballentine Partners Llc increased its stake in Facebook Inc (FB) by 4128.8% based on its latest 2017Q4 regulatory filing with the SEC. Ballentine Partners Llc bought 20,644 shares as the company’s stock declined 14.10% with the market. The institutional investor held 21,144 shares of the technology company at the end of 2017Q4, valued at $3.73M, up from 500 at the end of the previous reported quarter. Ballentine Partners Llc who had been investing in Facebook Inc for a number of months, seems to be bullish on the $480.02B market cap company. The stock decreased 0.43% or $0.72 during the last trading session, reaching $165.56. About 17.60 million shares traded. Facebook, Inc. (NASDAQ:FB) has risen 8.48% since April 23, 2017 and is uptrending. It has underperformed by 3.07% the S&P500.

Among 55 analysts covering Facebook (NASDAQ:FB), 50 have Buy rating, 2 Sell and 3 Hold. Therefore 91% are positive. Facebook had 254 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Friday, January 12 by RBC Capital Markets. The stock has “Buy” rating by Wells Fargo on Wednesday, April 4. As per Thursday, November 5, the company rating was maintained by Monness Crespi & Hardt. The firm has “Buy” rating given on Thursday, November 2 by Canaccord Genuity. The rating was maintained by Bank of America on Monday, July 24 with “Buy”. The stock of Facebook, Inc. (NASDAQ:FB) earned “Strong Buy” rating by Raymond James on Friday, January 13. The stock has “Buy” rating by Jefferies on Thursday, January 28. As per Tuesday, September 8, the company rating was initiated by Moffett Nathanson. Bank of America maintained the stock with “Buy” rating in Tuesday, March 27 report. The firm earned “Buy” rating on Wednesday, October 11 by Piper Jaffray.

Investors sentiment increased to 1.21 in Q4 2017. Its up 0.06, from 1.15 in 2017Q3. It increased, as 57 investors sold FB shares while 621 reduced holdings. 147 funds opened positions while 670 raised stakes. 1.61 billion shares or 1.26% less from 1.63 billion shares in 2017Q3 were reported. Associated Banc owns 1.15% invested in Facebook, Inc. (NASDAQ:FB) for 120,369 shares. Kornitzer Capital Ks has invested 0.68% in Facebook, Inc. (NASDAQ:FB). Eagle Ltd Llc stated it has 79,502 shares or 0.44% of all its holdings. Meiji Yasuda Asset Limited reported 100,291 shares. Pictet North America Advsr reported 107,714 shares stake. Cwm Limited Com owns 4,420 shares. Bokf Na has 153,179 shares. Kepos Cap Lp reported 0.43% in Facebook, Inc. (NASDAQ:FB). Tealwood Asset Inc holds 0.72% or 10,988 shares. Accuvest Advisors invested 0.05% in Facebook, Inc. (NASDAQ:FB). Stearns Ser Group Inc holds 1,257 shares or 0.05% of its portfolio. Marshall And Sullivan Inc Wa reported 3.22% of its portfolio in Facebook, Inc. (NASDAQ:FB). 16,265 were reported by Paragon Capital Limited. Moreover, Argi Services Ltd Liability Corp has 0.09% invested in Facebook, Inc. (NASDAQ:FB) for 7,804 shares. Neville Rodie And Shaw reported 45,352 shares.

Ballentine Partners Llc, which manages about $4.78 billion and $1.83 billion US Long portfolio, decreased its stake in Vanguard Intl Equity Index F (VWO) by 23,052 shares to 988,354 shares, valued at $45.38 million in 2017Q4, according to the filing. It also reduced its holding in American Express Co (NYSE:AXP) by 3,710 shares in the quarter, leaving it with 5,458 shares, and cut its stake in Unitedhealth Group Inc (NYSE:UNH).

Since October 24, 2017, it had 0 buys, and 42 selling transactions for $1.42 billion activity. $4.82 million worth of Facebook, Inc. (NASDAQ:FB) shares were sold by Schroepfer Michael Todd. $39.91 million worth of Facebook, Inc. (NASDAQ:FB) was sold by Zuckerberg Mark on Wednesday, March 7. On Friday, January 26 the insider FISCHER DAVID B. sold $1.05 million. Stretch Colin had sold 750 shares worth $129,325 on Tuesday, October 24. Cox Christopher K sold $2.83M worth of Facebook, Inc. (NASDAQ:FB) on Thursday, December 7. Another trade for 1.25M shares valued at $221.33M was made by Koum Jan on Thursday, February 15.

Financial Consulate Inc, which manages about $333.98 million and $195.69M US Long portfolio, upped its stake in Rydex Etf Trust (RPG) by 6,703 shares to 98,255 shares, valued at $10.30M in 2017Q4, according to the filing. It also increased its holding in General Electric Co (NYSE:GE) by 136,980 shares in the quarter, for a total of 158,453 shares, and has risen its stake in Schwab Strategic Tr (FNDX).

Analysts await Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) to report earnings on May, 1. They expect $-0.89 earnings per share, down 17.11% or $0.13 from last year’s $-0.76 per share. After $-1.38 actual earnings per share reported by Aerie Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -35.51% EPS growth.

Investors sentiment decreased to 1.2 in 2017 Q4. Its down 0.53, from 1.73 in 2017Q3. It is negative, as 23 investors sold AERI shares while 48 reduced holdings. 21 funds opened positions while 64 raised stakes. 34.86 million shares or 1.29% more from 34.42 million shares in 2017Q3 were reported. Teachers Retirement Sys Of The State Of Kentucky stated it has 0.04% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). Castleark Ltd holds 0.08% or 45,223 shares in its portfolio. Ny State Common Retirement Fund reported 0% stake. 52,620 were reported by Macquarie Gp Limited. United Kingdom-based Gsa Limited Liability Partnership has invested 0.06% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). Proshare Advsrs Ltd Company has invested 0.01% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). First Mercantile reported 0.08% stake. Citigroup owns 82,766 shares. Susquehanna Limited Liability Partnership has invested 0% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). Atlantic Trust Group Inc Limited Liability Co invested 0% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). Platinum Inv Ltd accumulated 37,600 shares. Wellington Gp Ltd Liability Partnership has 0.07% invested in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) for 5.06M shares. Voya Investment Mgmt Limited Liability Company accumulated 397,928 shares. Dafna Cap Mgmt Ltd holds 3.76% of its portfolio in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) for 116,770 shares. 4,160 were reported by Great West Life Assurance Com Can.

Facebook, Inc. (NASDAQ:FB) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>